Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | PGR | P06401 | 2/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | SELP | P16109 | 5/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.31 |
| ▸ | MMP12 | P39900 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAG | P20916 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5270133 | 1.00 | NOD2 (0.57) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL3229330 | 1.00 | NOD2 (0.57) | NOD2MAPK1ESR1PGRHTR1A | |
| Water SCHEMBL769017 | 0.99 | NOD2 (0.57) | NOD2MAPK1ESR1PGRHTR1A | |
| Alanine SCHEMBL11120060 | 0.98 | NOD2 (0.56) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL4450131 | 0.94 | NOD2 (0.55) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL4452390 | 0.94 | NOD2 (0.55) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL10598564 | 0.94 | MAPK1 (0.57) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL8203776 | 0.94 | NOD2 (0.52) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL8539918 | 0.93 | NOD2 (0.55) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL4446205 | 0.93 | NOD2 (0.55) | NOD2MAPK1ESR1PGRHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1611 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025006896-A1 | LOW DOSE MURAMYL DIPEPTIDE ANALOGUE-CONTAINING COMPOSITIONS AND METHODS OF USING SAME FOR IMMUNOPROTECTION | NUTRIVERT INC. (US) | 2025-01-02 | — | — | WO | claimed |
| EP-4368207-A2 | OVARIAN CANCER VACCINES | The Cleveland Clinic Foundation (US) | 2024-05-15 | — | — | EP | claimed |
| EP-3785729-B1 | OVARIAN CANCER VACCINES | CLEVELAND CLINIC FOUND (US) | 2024-03-13 | — | — | EP | claimed |
| CN-117244049-A | Pathogen vaccines and methods of producing and using the same | 哈佛学院院长等 | 2023-12-19 | — | — | CN | claimed |
| US-20230381298-A1 | HERPESVIRUS POLYEPITOPE VACCINES | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2023-11-30 | — | — | US | claimed |
| CN-108697778-B | Pathogen vaccines and methods of producing and using the same | 哈佛学院院长等 | 2023-10-03 | — | — | CN | claimed |
| EP-4225363-A1 | HERPESVIRUS POLYEPITOPE VACCINES | The Council of the Queensland Institute of Medical Research (AU) | 2023-08-16 | — | — | EP | claimed |
| CN-116528896-A | Herpesvirus multi-epitope vaccine | 昆士兰医学研究所理事会 | 2023-08-01 | — | — | CN | claimed |
| US-20220118030-A1 | BACTERIAL MEMBRANE PREPARATIONS | HORIZON TECHNOLOGY FINANCE CORPORATION | 2022-04-21 | — | — | US | claimed |
| WO-2022074455-A1 | HERPESVIRUS POLYEPITOPE VACCINES | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2022-04-14 | — | — | WO | claimed |
| EP-0157753-A1 | New somatostatin compounds, process for their synthesis, preparation for veterinary use containing said compound and process for the treatment of animals | TECHLAND, Société Anonyme (BE) | 1985-10-09 | — | — | EP | claimed |
| US-4522811-A | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides | SYNTEX (U.S.A.) INC. (US) | 1985-06-11 | — | — | US | claimed |
| EP-0135376-A2 | Polyoxypropylene-polyoxyethylene block polymer based adjuvants and vaccines using them | SYNTEX (U.S.A.) INC. (US) | 1985-03-27 | — | — | EP | claimed |
| EP-0100734-A1 | Process for the separation or purification of a sleep promoting factor from a biological source by immunological reaction of the antigen-antibody kind | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1984-02-15 | — | — | EP | claimed |
| EP-0089290-A1 | Conjugates of haptenes and muramyl peptides having an immunogenic activity, and compositions containing them | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1983-09-21 | — | — | EP | claimed |
| US-4357322-A | ADMINISTERING MURAMYL OR DESMETHYLMURAMYL DIPEPTIDES | SYNTEX (U.S.A.) INC. (US) | 1982-11-02 | — | — | US | claimed |
| US-4186194-A | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1980-01-29 | — | — | US | claimed |
| US-4172125-A | Oil-free adjuvant compositions containing N-acetyl-muramyl-L-alanyl-D-glutamic acid and method of use | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1979-10-23 | — | — | US | claimed |
| US-4158052-A | Oil-free adjuvant compositions containing N-acetyl-muramyl-L-alanyl-D-isoglutamine | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1979-06-12 | — | — | US | claimed |
| US-4125603-A | PROTEIN | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1978-11-14 | — | — | US | claimed |